MA
LLY icon

MYDA Advisors’s Eli Lilly LLY Stock Holding History

MYDA Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,800
Closed -$6.25M – 205
2026
Q1 		$6.25M Buy
+6,800
New +$6.89M 1.03% 25
2025
Q4 		– Sell
-3,000
Closed -$2.29M – 178
2025
Q3 		$2.29M Buy
+3,000
New +$2.23M 0.49% 61
2023
Q3 		– Sell
-14,000
Closed -$6.57M – 136
2023
Q2 		$6.57M Buy
+14,000
New +$5.87M 1.97% 16
2019
Q1 		– Sell
-12,000
Closed -$1.39M – 127
2018
Q4 		$1.39M Buy
+12,000
New +$1.34M 2.39% 13

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MYDA Advisors's LLY Position: Q2 2026 in Review

MYDA Advisors sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 6,800 shares — an estimated $6.25M sold.

MYDA Advisors first reported a position in LLY in Q4 2018 and held it in 4 quarters. The position peaked at $6.57M in Q2 2023. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MYDA Advisors reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • MYDA Advisors sold 6,800 Eli Lilly shares in Q2 2026, an estimated $6.25M.
  • MYDA Advisors first reported a position in Eli Lilly in Q4 2018 and held it in 4 quarters.
  • MYDA Advisors's Eli Lilly position peaked at $6.57M in Q2 2023.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.